Lam Research Corporation $LRCX Shares Sold by Krilogy Financial LLC

Krilogy Financial LLC lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 14.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,527 shares of the semiconductor company’s stock after selling 3,990 shares during the period. Krilogy Financial LLC’s holdings in Lam Research were worth $4,027,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Brighton Jones LLC increased its holdings in Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after purchasing an additional 12,936 shares during the period. Caxton Associates LLP purchased a new position in shares of Lam Research in the 1st quarter valued at about $239,000. Gabelli Funds LLC purchased a new position in shares of Lam Research in the 2nd quarter valued at about $253,000. NewEdge Advisors LLC grew its position in shares of Lam Research by 2.7% during the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock worth $9,785,000 after buying an additional 2,661 shares in the last quarter. Finally, Osterweis Capital Management Inc. grew its position in shares of Lam Research by 5,206.7% during the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after buying an additional 781 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

LRCX has been the topic of several analyst reports. Needham & Company LLC raised their target price on shares of Lam Research from $250.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, January 29th. Sanford C. Bernstein boosted their price target on shares of Lam Research from $275.00 to $285.00 and gave the stock an “outperform” rating in a report on Monday, February 9th. Argus increased their price objective on shares of Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. UBS Group set a $300.00 price objective on shares of Lam Research in a report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $300.00 target price on shares of Lam Research in a research note on Wednesday. Twenty-seven investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and an average price target of $247.26.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the transaction, the director owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares in the company, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 130,886 shares of company stock worth $29,658,802 over the last 90 days. Corporate insiders own 0.31% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Analyst write-ups and feature coverage highlight record semiconductor manufacturing demand and an upcoming “massive investor update” that could reinforce bullish guidance; the story frames Lam as a primary beneficiary of industry capacity expansion. Lam Research Stock Analysis: Buy or Sell Before the Massive Investor Update?
• Positive Sentiment: Zacks says Lam is likely to beat Q3 estimates as strong AI-chip demand and rising DRAM capex lift equipment spending — expectations for an earnings beat are directly supportive of the share rally. LRCX Likely to Beat Q3 Earnings Estimates: How to Play the Stock?
• Positive Sentiment: A separate Zacks preview urges investors to look beyond headline EPS/revenue — highlighting margin drivers and backlog indicators that could validate stronger-than-expected results and lift sentiment if reported. Lam Research (LRCX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
• Positive Sentiment: Reports that Elon Musk’s Terafab project is contacting semiconductor equipment suppliers raise the theoretical prospect of new, large-scale customers for makers of chip fabrication tools — a longer‑term demand driver for suppliers like Lam. Tesla, SpaceX Search For Suppliers For Elon Musk’s Terafab Project: Report
• Neutral Sentiment: Barron’s research/ratings page is updated — useful for tracking analyst coverage but it presents no single new catalyst; check for any rating or target changes that could move the stock. Lam Research Corp.
• Neutral Sentiment: Industry tracker: TSMC beat and raised its outlook, signaling broad AI-driven capacity growth that supports Lam’s end market — but the note also flags geopolitical and macro uncertainties that could affect timing or spending. Stocks to Watch: TSMC, Abbott Laboratories, Nvidia, Netflix

Lam Research Stock Performance

Shares of Lam Research stock opened at $267.60 on Monday. The firm has a market capitalization of $334.17 billion, a P/E ratio of 54.84, a P/E/G ratio of 2.85 and a beta of 1.78. Lam Research Corporation has a 52 week low of $61.14 and a 52 week high of $273.50. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The firm’s 50 day moving average is $231.88 and its two-hundred day moving average is $194.49.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the firm earned $0.91 EPS. The company’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th were given a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. Lam Research’s payout ratio is 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.